Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. freshman Avg
|
New words:
Academy, adjuvant, Anstalt, Axe, backlog, batch, Baxter, Benjamin, blocker, Boondock, breach, British, cast, CDRB, Century, CEO, chart, Chinese, chloride, Columbia, Companny, Conn, contact, Corn, creation, drew, Emprise, Entertainment, exceeding, explore, FCMA, Feeln, Fellow, Film, floor, Fondinvest, formula, Fox, Fried, fusion, Gamble, GlaxoSmithKline, Godzilla, Grace, GSK, Hallmark, Healthspan, heavy, Ideation, IDI, illustrate, Immune, Imputation, inflation, interpolating, Jeff, Jeremy, King, Lentiviral, linearly, MabVax, Maple, Married, matching, metric, modified, motion, multiplying, Murderer, Nonoperating, nonrenewable, outsourced, panel, pharma, picture, pivotal, played, Procter, profile, protocol, Purple, ready, Rebel, reclassifying, redacted, redeemed, repaid, resale, resell, residual, resource, Rob, Robert, Rudy, SAS, Savoy, seal, shelf, Silver, slight, SmallCap, SPA, SROne, strong, subtracting, sudden, Suntava, SVP, TLR, Twentieth, unanimously, unaudited, unchanged, Unilever, vaccine, Valley, Valor, VBI, vector, verification, Verified, verify, video
Removed:
AMEX, anticancer, assisted, bacteria, banker, billboard, biopharmaceutical, Castle, catalog, CDSI, cell, choice, cholesterol, clearing, Coif, cover, developer, discovery, engineered, eventually, executing, Farm, genetically, graduated, inception, Intellect, Ivax, IVC, IVD, mail, marketable, McGladrey, merchant, niacin, OMMH, Omnimmune, owner, pain, pecuniary, Pluristem, positioning, possessing, practicing, premium, PSTI, ROX, SCLL, SearchMedia, seeking, semantic, Sorrento, Stem, television, Transworld, twenty, Winston, WPHM
Filing tables
Filing exhibits
- 10-K Annual report
- 4.1 Form of Stock Certificate Representing Shares of Chromadex Corporation Common Stock
- 10.44 Joint Development Agreement
- 23.1 Consent of Marcum, LLP, Independent Registered Public Accounting Firm
- 31.1 Certification of the Chief Executive Officer Pursuant to ?240.13A-14 or ?240.15D-14 of the Securities Exchange Act of 1934, As Amended
- 31.2 Certification of the Chief Financial Officer Pursuant to ?240.13A-14 or ?240.15D-14 of the Securities Exchange Act of 1934, As Amended
- 32.1 Certification Pursuant to 18 U.s.c. Section 1350 (As Adopted Pursuant to Section 906 of the Sarbanes-oxley Act of 2002)
- Download Excel data file
- View Excel data file
CDXC similar filings
Filing view
External links
Exhibit 23.1
INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM’S CONSENT
We consent to the incorporation by reference in the Registration Statements of ChromaDex Corporation and Subsidiaries on Form S-3 and as amended [File No. 333-203204] and on Form S-8 [File No. 333-196434, File No. 333-168029, File No. 333-154402, and File No. 333-154403] of our report dated March 17, 2016, with respect to our audits of the consolidated financial statements of ChromaDex Corporation and Subsidiaries as of January 2, 2016 and January 3, 2015 and for the years ended January 2, 2016, January 3, 2015 and December 28, 2013 and our report dated March 17, 2016 with respect to our audit of the effectiveness of internal control over financial reporting of ChromaDex Corporation and Subsidiaries as of January 2, 2016, which reports are included in this Annual Report on Form 10-K of ChromaDex Corporation and Subsidiaries for the year ended January 2, 2016.
/s/ Marcum llp
Marcum llp
New York, NY
March 17, 2016